> top > projects > sonoma2 > docs > PubMed:33004076 > annotations
sonoma2  

PubMed:33004076 JSONTXT

Annnotations TAB TSV DIC JSON TextAE Lectin_function IAV-Glycan

Id Subject Object Predicate Lexical cue
T0 0-6 GENE denotes Dnmt3b
T1 7-16 REG denotes regulates
T2 17-21 GENE denotes DUX4
T3 22-32 MPA denotes expression
T4 65-80 VAR denotes transgenic D4Z4
T5 99-137 DISEASE denotes Facioscapulohumeral muscular dystrophy
T6 118-136 DISEASE denotes muscular dystroph
T7 138-142 DISEASE denotes (FSH
T8 139-143 DISEASE denotes FSHD
T9 149-173 DISEASE denotes skeletal muscle disorde
T10 150-174 DISEASE denotes skeletal muscle disorder
T11 183-189 REG denotes caused
T12 193-205 POSREG denotes derepression
T13 233-237 GENE denotes DUX
T14 234-238 GENE denotes DUX4
T15 242-263 CPA denotes skeletal muscle cells
T16 275-281 GENE denotes SMCHD
T17 276-282 GENE denotes SMCHD1
T18 283-289 GENE denotes DNMT3
T19 284-290 GENE denotes DNMT3B
T20 304-314 REG denotes identified
T21 320-327 REG denotes disease
T22 337-353 MPA denotes disease modifier
T23 356-360 DISEASE denotes FSH
T24 357-361 DISEASE denotes FSHD
T25 382-386 REG denotes role
T26 389-395 GENE denotes DNMT3
T27 390-396 GENE denotes DNMT3B
T28 404-408 VAR denotes D4Z4
T29 409-415 VAR denotes repeat
T30 430-437 REG denotes unknown
T31 465-469 REG denotes role
T32 471-477 GENE denotes f Dnmt
T33 473-479 GENE denotes Dnmt3b
T34 481-485 GENE denotes n DU
T35 483-487 GENE denotes DUX4
T36 488-498 NEGREG denotes repression
T37 500-510 VAR denotes hemizygous
T38 521-531 DISEASE denotes a FSHD-siz
T39 534-551 VAR denotes D4Z4 repeat array
T40 553-561 VAR denotes D4Z4-2.5
T41 594-602 REG denotes carrying
T42 620-637 VAR denotes skipping mutation
T43 639-645 GENE denotes n Dnmt
T44 641-647 GENE denotes Dnmt3b
T45 649-663 VAR denotes Dnmt3bMommeD14
T46 685-701 VAR denotes siRNA knockdowns
T47 703-709 GENE denotes f Dnmt
T48 705-711 GENE denotes Dnmt3b
T49 717-726 REG denotes performed
T50 782-790 VAR denotes D4Z4-2.5
T51 835-843 VAR denotes D4Z4-2.5
T52 847-853 GENE denotes e, Dnm
T53 850-856 GENE denotes Dnmt3b
T54 861-869 POSREG denotes enriched
T55 877-881 VAR denotes D4Z4
T56 896-900 GENE denotes nd D
T57 899-903 GENE denotes DUX4
T58 904-921 MPA denotes transcript levels
T59 927-938 POSREG denotes upregulated
T60 947-956 VAR denotes knockdown
T61 957-963 GENE denotes of Dnm
T62 960-966 GENE denotes Dnmt3b
T63 971-994 VAR denotes D4Z4-2.5/Dnmt3bMommeD14
T64 998-1004 GENE denotes e, Dnm
T65 1008-1022 MPA denotes protein levels
T66 1028-1035 NEGREG denotes reduced
T67 1043-1047 GENE denotes r, D
T68 1046-1050 GENE denotes DUX4
T69 1051-1061 MPA denotes RNA levels
T70 1065-1081 CPA denotes skeletal muscles
T71 1087-1090 NEGREG denotes not
T72 1091-1099 POSREG denotes enhanced
T73 1104-1106 NEGREG denotes no
T74 1107-1116 CPA denotes pathology
T75 1121-1129 REG denotes observed
T76 1146-1169 VAR denotes D4Z4-2.5/Dnmt3bMommeD14
T77 1175-1181 REG denotes showed
T78 1184-1188 NEGREG denotes loss
T79 1192-1207 MPA denotes DNA methylation
T80 1251-1257 POSREG denotes higher
T81 1255-1259 GENE denotes er D
T82 1258-1262 GENE denotes DUX4
T83 1263-1280 MPA denotes transcript levels
T84 1284-1309 CPA denotes secondary lymphoid organs
T85 1347-1351 POSREG denotes more
T86 1352-1361 REG denotes sensitive
T87 1365-1385 MPA denotes epigenetic modifiers
T88 1393-1410 VAR denotes D4Z4 repeat array
T89 1422-1445 CPA denotes immune cell populations
T90 1451-1461 REG denotes quantified
T91 1504-1512 VAR denotes D4Z4-2.5
T92 1531-1545 VAR denotes Dnmt3bMommeD14
T93 1554-1567 VAR denotes Smchd1MommeD1
T94 1582-1604 VAR denotes D4Z4-2.5/Smchd1MommeD1
T95 1614-1637 CPA denotes immune cell populations
T96 1643-1652 NEGREG denotes disturbed
T97 1676-1688 REG denotes demonstrates
T98 1694-1698 VAR denotes loss
T99 1698-1704 GENE denotes of Dn
T100 1702-1708 GENE denotes Dnmt3b
T101 1709-1716 REG denotes results
T102 1720-1732 POSREG denotes derepression
T103 1732-1736 GENE denotes of
T104 1736-1740 GENE denotes DUX4
T105 1744-1760 CPA denotes lymphoid tissues
T106 1765-1770 CPA denotes mESCs
T107 1782-1796 CPA denotes myogenic cells
T108 1800-1823 VAR denotes D4Z4-2.5/Dnmt3bMommeD14
T109 1847-1860 VAR denotes Smchd1MommeD1
T110 1861-1868 VAR denotes variant
T111 1885-1896 POSREG denotes more potent
T112 1897-1901 REG denotes role
T113 1901-1905 GENE denotes in
T114 1905-1909 GENE denotes DUX4
T115 1910-1922 POSREG denotes derepression
T116 1953-1966 CPA denotes immune system
T117 2002-2011 REG denotes sensitive
T118 2015-2019 VAR denotes D4Z4
T119 2020-2039 MPA denotes chromatin modifiers
T120 2109-2120 REG denotes involvement
T121 2120-2124 DISEASE denotes in
T122 2124-2128 DISEASE denotes FSHD
R0 T0 T3 ThemeOf Dnmt3b,expression
R1 T0 T4 ThemeOf Dnmt3b,transgenic D4Z4
R10 T5 T12 ThemeOf Facioscapulohumeral muscular dystrophy,derepression
R100 T71 T73 CauseOf not,no
R101 T74 T73 ThemeOf pathology,no
R102 T73 T75 ThemeOf no,observed
R103 T74 T75 ThemeOf pathology,observed
R104 T76 T78 CauseOf D4Z4-2.5/Dnmt3bMommeD14,loss
R105 T76 T80 CauseOf D4Z4-2.5/Dnmt3bMommeD14,higher
R106 T78 T77 ThemeOf loss,showed
R107 T79 T78 ThemeOf DNA methylation,loss
R108 T79 T77 ThemeOf DNA methylation,showed
R109 T83 T80 ThemeOf transcript levels,higher
R11 T8 T10 ThemeOf FSHD,skeletal muscle disorder
R110 T82 T80 ThemeOf DUX4,higher
R111 T82 T83 ThemeOf DUX4,transcript levels
R112 T82 T84 ThemeOf DUX4,secondary lymphoid organs
R113 T83 T84 ThemeOf transcript levels,secondary lymphoid organs
R114 T84 T80 ThemeOf secondary lymphoid organs,higher
R115 T86 T85 ThemeOf sensitive,more
R116 T87 T85 ThemeOf epigenetic modifiers,more
R117 T86 T87 ThemeOf sensitive,epigenetic modifiers
R118 T88 T86 ThemeOf D4Z4 repeat array,sensitive
R119 T89 T86 ThemeOf immune cell populations,sensitive
R12 T8 T11 ThemeOf FSHD,caused
R120 T86 T90 ThemeOf sensitive,quantified
R121 T88 T87 ThemeOf D4Z4 repeat array,epigenetic modifiers
R122 T89 T87 ThemeOf immune cell populations,epigenetic modifiers
R123 T87 T90 ThemeOf epigenetic modifiers,quantified
R124 T88 T90 ThemeOf D4Z4 repeat array,quantified
R125 T89 T85 ThemeOf immune cell populations,more
R126 T89 T90 ThemeOf immune cell populations,quantified
R127 T91 T90 ThemeOf D4Z4-2.5,quantified
R128 T94 T96 CauseOf D4Z4-2.5/Smchd1MommeD1,disturbed
R129 T95 T96 ThemeOf immune cell populations,disturbed
R13 T8 T12 ThemeOf FSHD,derepression
R130 T98 T97 CauseOf loss,demonstrates
R131 T98 T96 CauseOf loss,disturbed
R132 T98 T101 CauseOf loss,results
R133 T98 T102 CauseOf loss,derepression
R134 T100 T98 ThemeOf Dnmt3b,loss
R135 T102 T101 ThemeOf derepression,results
R136 T105 T102 ThemeOf lymphoid tissues,derepression
R137 T104 T102 ThemeOf DUX4,derepression
R138 T104 T105 ThemeOf DUX4,lymphoid tissues
R139 T105 T101 ThemeOf lymphoid tissues,results
R14 T10 T11 ThemeOf skeletal muscle disorder,caused
R140 T106 T102 ThemeOf mESCs,derepression
R141 T107 T108 ThemeOf myogenic cells,D4Z4-2.5/Dnmt3bMommeD14
R142 T109 T110 ThemeOf Smchd1MommeD1,variant
R143 T109 T111 CauseOf Smchd1MommeD1,more potent
R144 T109 T115 CauseOf Smchd1MommeD1,derepression
R145 T110 T111 CauseOf variant,more potent
R146 T110 T115 CauseOf variant,derepression
R147 T112 T111 ThemeOf role,more potent
R148 T115 T111 ThemeOf derepression,more potent
R149 T114 T112 ThemeOf DUX4,role
R15 T10 T12 ThemeOf skeletal muscle disorder,derepression
R150 T115 T112 ThemeOf derepression,role
R151 T114 T110 ThemeOf DUX4,variant
R152 T114 T111 ThemeOf DUX4,more potent
R153 T114 T115 ThemeOf DUX4,derepression
R154 T116 T117 ThemeOf immune system,sensitive
R155 T118 T117 ThemeOf D4Z4,sensitive
R156 T119 T117 ThemeOf chromatin modifiers,sensitive
R157 T118 T119 ThemeOf D4Z4,chromatin modifiers
R158 T122 T120 ThemeOf FSHD,involvement
R16 T11 T12 CauseOf caused,derepression
R17 T15 T12 ThemeOf skeletal muscle cells,derepression
R18 T14 T12 ThemeOf DUX4,derepression
R19 T14 T15 ThemeOf DUX4,skeletal muscle cells
R2 T3 T1 ThemeOf expression,regulates
R20 T17 T20 ThemeOf SMCHD1,identified
R21 T17 T21 ThemeOf SMCHD1,disease
R22 T17 T22 ThemeOf SMCHD1,disease modifier
R23 T19 T20 ThemeOf DNMT3B,identified
R24 T19 T21 ThemeOf DNMT3B,disease
R25 T19 T22 ThemeOf DNMT3B,disease modifier
R26 T21 T20 ThemeOf disease,identified
R27 T22 T20 ThemeOf disease modifier,identified
R28 T24 T20 ThemeOf FSHD,identified
R29 T24 T21 ThemeOf FSHD,disease
R3 T2 T1 ThemeOf DUX4,regulates
R30 T24 T22 ThemeOf FSHD,disease modifier
R31 T27 T25 ThemeOf DNMT3B,role
R32 T28 T25 ThemeOf D4Z4,role
R33 T29 T25 ThemeOf repeat,role
R34 T25 T30 ThemeOf role,unknown
R35 T27 T28 ThemeOf DNMT3B,D4Z4
R36 T27 T29 ThemeOf DNMT3B,repeat
R37 T27 T30 ThemeOf DNMT3B,unknown
R38 T28 T29 ThemeOf D4Z4,repeat
R39 T33 T31 ThemeOf Dnmt3b,role
R4 T2 T3 ThemeOf DUX4,expression
R40 T31 T36 ThemeOf role,repression
R41 T33 T36 ThemeOf Dnmt3b,repression
R42 T33 T37 ThemeOf Dnmt3b,hemizygous
R43 T33 T39 ThemeOf Dnmt3b,D4Z4 repeat array
R44 T35 T31 ThemeOf DUX4,role
R45 T35 T36 ThemeOf DUX4,repression
R46 T35 T37 ThemeOf DUX4,hemizygous
R47 T37 T36 CauseOf hemizygous,repression
R48 T41 T36 CauseOf carrying,repression
R49 T39 T37 ThemeOf D4Z4 repeat array,hemizygous
R5 T2 T4 ThemeOf DUX4,transgenic D4Z4
R50 T40 T37 ThemeOf D4Z4-2.5,hemizygous
R51 T39 T31 ThemeOf D4Z4 repeat array,role
R52 T39 T40 ThemeOf D4Z4 repeat array,D4Z4-2.5
R53 T40 T36 CauseOf D4Z4-2.5,repression
R54 T42 T36 CauseOf skipping mutation,repression
R55 T44 T42 ThemeOf Dnmt3b,skipping mutation
R56 T45 T42 ThemeOf Dnmt3bMommeD14,skipping mutation
R57 T44 T37 ThemeOf Dnmt3b,hemizygous
R58 T44 T39 ThemeOf Dnmt3b,D4Z4 repeat array
R59 T44 T40 ThemeOf Dnmt3b,D4Z4-2.5
R6 T3 T4 ThemeOf expression,transgenic D4Z4
R60 T44 T41 ThemeOf Dnmt3b,carrying
R61 T44 T45 ThemeOf Dnmt3b,Dnmt3bMommeD14
R62 T45 T41 ThemeOf Dnmt3bMommeD14,carrying
R63 T46 T49 CauseOf siRNA knockdowns,performed
R64 T48 T46 ThemeOf Dnmt3b,siRNA knockdowns
R65 T48 T49 ThemeOf Dnmt3b,performed
R66 T48 T50 ThemeOf Dnmt3b,D4Z4-2.5
R67 T51 T54 ThemeOf D4Z4-2.5,enriched
R68 T51 T59 CauseOf D4Z4-2.5,upregulated
R69 T53 T51 ThemeOf Dnmt3b,D4Z4-2.5
R7 T4 T1 CauseOf transgenic D4Z4,regulates
R70 T53 T54 ThemeOf Dnmt3b,enriched
R71 T53 T55 ThemeOf Dnmt3b,D4Z4
R72 T53 T58 ThemeOf Dnmt3b,transcript levels
R73 T53 T60 ThemeOf Dnmt3b,knockdown
R74 T55 T54 ThemeOf D4Z4,enriched
R75 T54 T59 CauseOf enriched,upregulated
R76 T57 T51 ThemeOf DUX4,D4Z4-2.5
R77 T57 T54 ThemeOf DUX4,enriched
R78 T57 T55 ThemeOf DUX4,D4Z4
R79 T57 T58 ThemeOf DUX4,transcript levels
R8 T5 T10 ThemeOf Facioscapulohumeral muscular dystrophy,skeletal muscle disorder
R80 T57 T59 ThemeOf DUX4,upregulated
R81 T57 T60 ThemeOf DUX4,knockdown
R82 T58 T54 ThemeOf transcript levels,enriched
R83 T58 T59 ThemeOf transcript levels,upregulated
R84 T60 T54 CauseOf knockdown,enriched
R85 T60 T59 CauseOf knockdown,upregulated
R86 T62 T54 ThemeOf Dnmt3b,enriched
R87 T62 T60 ThemeOf Dnmt3b,knockdown
R88 T65 T63 ThemeOf protein levels,D4Z4-2.5/Dnmt3bMommeD14
R89 T65 T66 ThemeOf protein levels,reduced
R9 T5 T11 ThemeOf Facioscapulohumeral muscular dystrophy,caused
R90 T68 T69 ThemeOf DUX4,RNA levels
R91 T68 T70 ThemeOf DUX4,skeletal muscles
R92 T68 T71 ThemeOf DUX4,not
R93 T68 T72 ThemeOf DUX4,enhanced
R94 T69 T66 ThemeOf RNA levels,reduced
R95 T70 T69 ThemeOf skeletal muscles,RNA levels
R96 T69 T71 ThemeOf RNA levels,not
R97 T69 T72 ThemeOf RNA levels,enhanced
R98 T70 T71 ThemeOf skeletal muscles,not
R99 T70 T72 ThemeOf skeletal muscles,enhanced